GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 45 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 1,600 | +128.6% | 0.00% | – |
| Q1 2021 | $0 | – | 700 | -12.5% | 0.00% | – |
| Q4 2020 | $0 | – | 800 | +33.3% | 0.00% | – |
| Q3 2020 | $0 | – | 600 | -14.3% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 700 | -87.7% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 5,700 | +42.5% | 0.00% | – |
| Q4 2019 | $3,000 | – | 4,000 | +3900.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
| Q1 2019 | $3,000 | -96.2% | 400 | -96.6% | 0.00% | -100.0% |
| Q4 2018 | $80,000 | -7.0% | 11,700 | +4.5% | 0.01% | +16.7% |
| Q3 2018 | $86,000 | +8500.0% | 11,200 | +11100.0% | 0.01% | – |
| Q2 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 339,000 | $4,034,000 | 2.29% |
| Knoll Capital Management, LLC | 210,000 | $2,499,000 | 2.12% |
| BVF INC/IL | 1,761,567 | $20,963,000 | 2.05% |
| Vivo Capital, LLC | 792,707 | $9,433,000 | 1.22% |
| P.A.W. CAPITAL CORP | 95,000 | $1,131,000 | 1.14% |
| 683 Capital Management, LLC | 1,350,000 | $16,065,000 | 1.09% |
| Unterberg Capital LLC | 50,000 | $595,000 | 0.70% |
| SABBY MANAGEMENT, LLC | 232,224 | $2,763,000 | 0.43% |
| Nantahala Capital Management | 741,108 | $8,819,000 | 0.36% |
| DAFNA Capital Management LLC | 50,000 | $595,000 | 0.28% |